Join
Live feed
·
INSIDERFilingvia Quantisnow
Sana Biotechnology Inc. logo

EVP, Chief Scientific Officer Patel Dhavalkumar Dhirajlal converted options into 125,000 shares and covered exercise/tax liability with 41,158 shares, increasing direct ownership by 84% to 183,352 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SANA· Sana Biotechnology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SANA (Sana Biotechnology Inc.) and more on Quantisnow.